Trials / Completed
CompletedNCT03607812
Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice
ABPM (Automatic Measurement of Blood Pressure) Evaluation in the Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,027 (actual)
- Sponsor
- Merinal Laboratoires · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Blood pressure reduction and control are associated with reduced risk of stroke and cardiovascular disease. There is evidence that ambulatory blood pressure monitoring (ABPM) results more accurately reflect the risk of cardiovascular events than do office measurements of blood pressure. New international guidelines recognize the importance of ABPM which has an important and growing role in the diagnosis and in guiding antihypertensive therapy. In 2011 in the United Kingdom, the National Institute for Health and Care Excellence (NICE) recommended that ABPM be performed on all patients with suspected hypertension to confirm the diagnosis and reduce unnecessary treatment in people who do not have true hypertension. The aim of this observational study is to describe the utility of ABPM generally and specifically in the management of hypertension by Cardiologists in the Algerian context.
Detailed description
The primary Objective of this study is to assess the benefit of the ABPM in the diagnosis and management of arterial hypertension in by Cardiologists. The Secondary Objectives are: * To identify the conditions of usage of ABPM for the diagnosis of arterial hypertension, * To evaluate the blood pressure during the ABPM assessment and at 6 weeks of follow up * To describe the study population (socio-demography), * To describe the therapeutic stratégies and the compliance to treatment.
Conditions
Timeline
- Start date
- 2017-06-28
- Primary completion
- 2018-07-31
- Completion
- 2018-08-31
- First posted
- 2018-07-31
- Last updated
- 2019-08-20
Locations
1 site across 1 country: Algeria
Source: ClinicalTrials.gov record NCT03607812. Inclusion in this directory is not an endorsement.